Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$649M |
| 2 |
Nike
NKE
|
+$453M |
| 3 |
Tesla
TSLA
|
+$431M |
| 4 |
AstraZeneca
AZN
|
+$389M |
| 5 |
Coca-Cola
KO
|
+$336M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$897M |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$578M |
| 3 |
Moderna
MRNA
|
+$438M |
| 4 |
Apple
AAPL
|
+$417M |
| 5 |
Aon
AON
|
+$386M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.4% |
| 2 | Healthcare | 20.27% |
| 3 | Consumer Staples | 11.15% |
| 4 | Consumer Discretionary | 9.81% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILK
1851
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $2.78M | ﹤0.01% |
50,492
+13,092
| +35% | +$685K |
|
1852
WisdomTree India Earnings Fund ETF
EPI
$2.06B
| $2.77M | ﹤0.01% |
74,100
-50,000
| -40% | -$1.78M |
|
|
ACCD
1853
DELISTED
Accolade Inc
ACCD
| $2.77M | ﹤0.01% |
+65,700
| New | +$3.09M |
|
|
HMNF
1854
DELISTED
HMN Financial Inc
HMNF
| $2.76M | ﹤0.01% |
118,725
+1,800
| +2% | +$41K |
|
1855
Ampco-Pittsburgh
AP
$175M
| $2.76M | ﹤0.01% |
587,001
+17,300
| +3% | +$92.4K |
|
|
LITS
1856
Lite Strategy Inc
LITS
$32.2M
| $2.76M | ﹤0.01% |
49,939
-8,065
| -14% | -$444K |
|
1857
Green Plains
GPRE
$1.17B
| $2.75M | ﹤0.01% |
84,342
-250,501
| -75% | -$8.59M |
|
1858
iShares Expanded Tech-Software Sector ETF
IGV
$14.2B
| $2.75M | ﹤0.01% |
34,500
+18,000
| +109% | +$1.47M |
|
1859
Sonida Senior Living
SNDA
$1.87B
| $2.75M | ﹤0.01% |
78,191
-14,000
| -15% | -$500K |
|
|
AIV
1860
Aimco
AIV
$387M
| $2.75M | ﹤0.01% |
401,940
-913,000
| -69% | -$6.28M |
|
1861
Hyster-Yale Materials Handling
HY
$628M
| $2.75M | ﹤0.01% |
54,700
+9,300
| +20% | +$572K |
|
1862
Akebia Therapeutics
AKBA
$357M
| $2.74M | ﹤0.01% |
949,927
-877,803
| -48% | -$2.51M |
|
|
CCRN
1863
DELISTED
Cross Country Healthcare
CCRN
| $2.73M | ﹤0.01% |
128,618
-63,161
| -33% | -$1.18M |
|
|
LUMO
1864
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $2.72M | ﹤0.01% |
286,412
-19,345
| -6% | -$182K |
|
1865
National Health Investors
NHI
$3.61B
| $2.72M | ﹤0.01% |
50,900
-1,000
| -2% | -$62.5K |
|
|
UXIN
1866
Uxin Ltd
UXIN
$299M
| $2.72M | ﹤0.01% |
9,861
-10,733
| -52% | -$3.54M |
|
1867
Stride
LRN
$3.37B
| $2.71M | ﹤0.01% |
75,300
-107,596
| -59% | -$3.53M |
|
|
RVLP
1868
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
| $2.71M | ﹤0.01% |
917,049
-56,053
| -6% | -$188K |
|
1869
Liberty Media Series C
FWONK
$24.3B
| $2.7M | ﹤0.01% |
54,382
-146,248
| -73% | -$6.92M |
|
1870
Olema Pharmaceuticals
OLMA
$1.01B
| $2.7M | ﹤0.01% |
+97,900
| New | +$2.64M |
|
1871
Wingstop
WING
$3.51B
| $2.69M | ﹤0.01% |
16,410
-49,200
| -75% | -$8.34M |
|
1872
UMB Financial
UMBF
$11.1B
| $2.69M | ﹤0.01% |
+27,800
| New | +$2.54M |
|
1873
Coca-Cola Consolidated
COKE
$11.8B
| $2.68M | ﹤0.01% |
68,000
+2,000
| +3% | +$79.6K |
|
|
LKFT
1874
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.75B
| $2.68M | ﹤0.01% |
50,900
+40,700
| +399% | +$2.42M |
|
|
IMBI
1875
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
| $2.67M | ﹤0.01% |
464,358
-135,400
| -23% | -$869K |
|
Similar funds
Renaissance Technologies's Q3 2021 Portfolio in Review
As of Q3 2021, Renaissance Technologies held 4,070 positions worth $77.4B, down 3.3% from $80.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q3 2021 filing shows 663 new, 931 increased, 1,797 reduced and 653 closed positions. Its largest new stake was Adobe: 1,030,433 shares worth $593M. The largest sale was Amazon, an estimated $897M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Healthcare and Consumer Staples.
- Renaissance Technologies's largest Q3 2021 buy was Adobe: 1,030,433 shares worth $593M.
- Renaissance Technologies added most to Nike in Q3 2021, an estimated $453M increase.
- Renaissance Technologies's biggest Q3 2021 reduction was Moderna, cutting an estimated $438M.
- Renaissance Technologies fully exited Amazon in Q3 2021, selling an estimated $897M.
- Renaissance Technologies's ten largest holdings make up 12% of its $77.4B portfolio in Q3 2021.
- Renaissance Technologies opened 663 new positions and closed 653 in Q3 2021.
- Renaissance Technologies's portfolio value fell 3.3% quarter-over-quarter to $77.4B.
Based on Renaissance Technologies's 13F filing for Q3 2021, filed 12 Nov 2021.